| Bid Price | 12.75p | High Price | 13.75p |
|---|
| Ask Price | 13.50p | Low Price | 12.76p |
|---|
| Open Price | 13.38p | Spread | 5.56% |
|---|
| Prev Close | 12.50p | Volume | 321,332 |
|---|
Creo Medical Group PLC Historic Prices
| Date | Open | High | Low | Close | Volume |
|---|
| Aug 4, 2025 | 13.38 | 13.75 | 12.76 | 13.13 | 321,332 |
| Aug 1, 2025 | 13.25 | 13.50 | 12.50 | 12.50 | 321,369 |
| Jul 31, 2025 | 13.38 | 13.50 | 13.00 | 13.25 | 303,483 |
| Jul 30, 2025 | 13.63 | 14.00 | 12.75 | 13.38 | 492,171 |
| Jul 29, 2025 | 13.75 | 14.00 | 13.25 | 13.63 | 287,496 |
Creo Medical Group PLC Information
| Name | Creo Medical Group PLC | Index | FTSE AIM All Share |
|---|
| ISIN | GB00BZ1BLL44 | Epic | CREO |
|---|
| Type | Equity | Currency | GBX |
|---|
| Record Status | Active | Trading Segment | ASQ1 |
|---|
| Industry | Medical Devices | Sector | Healthcare |
|---|
| EMS | 30,000 | Trading Status | Closed |
|---|
| Shares in Issue | 412.47 m | Prev Close | 12.50p |
|---|
| PE Ratio | | Market Cap | £54.14 m |
|---|
| Div Yield | 0 | Div per Share | £NaN |
|---|
| EPS | -£0.05 | Div Cover | NaN |
|---|
| PEG | n/a | EPS Growth (%) | 0.00 |
|---|
| ROCE | -0.301199 | DPS Growth (%) | 0 |
|---|
| Current Ratio | 2.75122 | Quick Ratio | 0.487805 |
|---|
Creo Medical Group PLC Director Deals
| Declared | Type | Director | Pos. | Volume / Price | Value |
|---|
| 24/07/25 | BUY | Craig Gulliford | CEO | 6,429 @ £0.14 | £900.00 |
| 24/07/25 | BUY | Richard Rees | FD | 6,429 @ £0.14 | £900.00 |
| 02/06/25 | BUY | Kevin Crofton | CH | 701,750 @ £0.16 | £110,526.00 |
| 28/01/25 | BUY | Craig Gulliford | CEO | 9,424 @ £0.00 | £9.00 |
| 28/01/25 | BUY | Craig Gulliford | CEO | 4,712 @ £0.19 | £900.00 |
| 28/01/25 | BUY | Christopher Hancock | RES | 4,712 @ £0.19 | £900.00 |
| 28/01/25 | BUY | Christopher Hancock | RES | 9,424 @ £0.00 | £9.00 |
| 28/01/25 | BUY | Richard Rees | FD | 9,424 @ £0.00 | £9.00 |
| 28/01/25 | BUY | Richard Rees | FD | 4,712 @ £0.19 | £900.00 |
| 16/12/24 | BUY | Kevin Crofton | CH | 1,179,000 @ £0.17 | £200,607.00 |
Creo Medical Group PLC News
